Granules India Limited (GRANULES) Share Analysis
NSE · Healthcare · Pharmaceuticals
Granules India Limited (NSE: GRANULES) is an Indian listed company in the Pharmaceuticals sector and a constituent of NIFTY 500, NIFTY MidSmallcap 400, NIFTY Smallcap 250. As of 21 Sep 2026, the share price was ₹876.00, market capitalisation ₹23,882 Cr, P/E 36.7, ROE 13.8%.
Get the AI verdict on GRANULES: BUY, BUY ON DIPS, WAIT or EXIT
Sign in for the full analysis — AI fundamental and technical analysis, recent news, and one verdict with an entry zone, two targets and a stop-loss, for a 3-month, 1-year, 3-year or 5-year horizon. A free plan is available.
Stored fundamentals as of 21 Sep 2026 — not a live quote. Signed-in analysis uses same-day data.
GRANULES price and valuation
- Share price
- ₹876.00
- Market cap
- ₹23,882 Cr
- P/E ratio
- 36.7
- P/B ratio
- 4.27
- EPS
- ₹26.96
- Book value per share
- ₹205.00
- Dividend yield
- 0.2%
GRANULES profitability and growth
- ROE
- 13.8%
- ROCE
- 15.5%
- Debt to equity
- 0.3
- Revenue growth (3 yr)
- 6%
- Revenue growth (5 yr)
- 11%
- Profit growth (3 yr)
- 5%
- Profit growth (5 yr)
- 2%
GRANULES 52-week range
- 52-week high
- ₹923.65
- 52-week low
- ₹510.55
- Face value
- ₹1.00
GRANULES shareholding pattern
- Promoters
- 38.01%
- FIIs
- 17.5%
- DIIs
- 16.11%
- Public
- 28.36%
Index membership: NIFTY 500, NIFTY MidSmallcap 400, NIFTY Smallcap 250.
Learn to read these numbers
- Metrics glossary — what P/E, ROE, ROCE and debt-to-equity mean.
- Investment Blogs — free lessons on fundamental and technical analysis.
- AI stock picks and Discover stocks by sector and index.
- How Stock-Analyze works — what the AI analysis and verdict cover.